Healthcare provider profile · identity verified

Jenifer Rose Combs, CNP

Nurse Practitioner · WHEELERSBURG, OH · NPI 1932493871

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	333	70
Atorvastatin Calcium	Atorvastatin Calcium	243	58
Lisinopril	Lisinopril	236	54
Amlodipine Besylate	Amlodipine Besylate	181	42
Losartan Potassium	Losartan Potassium	174	47
Furosemide	Furosemide	135	31
Metformin Hcl	Metformin Hcl	124	31
Buspirone Hcl	Buspirone Hcl	122	29
Potassium Chloride	Potassium Chloride	112	31
Gabapentin	Gabapentin	110	20
Pantoprazole Sodium	Pantoprazole Sodium	110	25
Metoprolol Tartrate	Metoprolol Tartrate	105	25
Metoprolol Succinate	Metoprolol Succinate	101	31
Ozempic	Semaglutide	100	14
Sertraline Hcl	Sertraline Hcl	98	20
Ibuprofen	Ibuprofen	96	21
Jardiance	Empagliflozin	93	18
Omeprazole	Omeprazole	90	20
Montelukast Sodium	Montelukast Sodium	87	16
Famotidine	Famotidine	85	21
Tamsulosin Hcl	Tamsulosin Hcl	85	19
Hydrochlorothiazide	Hydrochlorothiazide	82	25
Pravastatin Sodium	Pravastatin Sodium	82	22
Albuterol Sulfate Hfa	Albuterol Sulfate	80	25
Simvastatin	Simvastatin	72	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	71	14
Rosuvastatin Calcium	Rosuvastatin Calcium	71	18
Trazodone Hcl	Trazodone Hcl	64	12
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	59	17
Clopidogrel	Clopidogrel Bisulfate	53	suppressed
Lorazepam	Lorazepam	53	suppressed
Pregabalin	Pregabalin	53	suppressed
Tramadol Hcl	Tramadol Hcl	53	11
Donepezil Hcl	Donepezil Hcl	52	12
Fenofibrate	Fenofibrate	52	16
Alprazolam	Alprazolam	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	50	23
Mounjaro	Tirzepatide	50	suppressed
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Januvia	Sitagliptin Phosphate	45	13
Pioglitazone Hcl	Pioglitazone Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	11
Tresiba Flextouch U-100	Insulin Degludec	42	suppressed
Trulicity	Dulaglutide	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Methylprednisolone	Methylprednisolone	36	27
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	36	12
Primidone	Primidone	34	suppressed
Baclofen	Baclofen	33	13
Nystatin	Nystatin	32	17
Atenolol	Atenolol	30	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	30	suppressed
Tradjenta	Linagliptin	30	suppressed
Finasteride	Finasteride	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Alendronate Sodium	Alendronate Sodium	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Cephalexin	Cephalexin	25	19
Valsartan	Valsartan	24	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	22	suppressed
Prednisone	Prednisone	22	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	21	suppressed
Methocarbamol	Methocarbamol	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Carvedilol	Carvedilol	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Nebivolol Hcl	Nebivolol Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Jentadueto	Linagliptin/Metformin Hcl	19	suppressed
Sucralfate	Sucralfate	19	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Fluconazole	Fluconazole	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Linzess	Linaclotide	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Celecoxib	Celecoxib	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	14	suppressed
Diclofenac Potassium	Diclofenac Potassium	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Repaglinide	Repaglinide	14	suppressed
Amoxicillin	Amoxicillin	13	11
Levetiracetam	Levetiracetam	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Bystolic	Nebivolol Hcl	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error